• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION SYNVISC ONE PFS 8MG; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION SYNVISC ONE PFS 8MG; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Patient Problems Calcium Deposits/Calcification (1758); Fall (1848)
Event Type  Injury  
Event Description
The pt's wife reports the pt having kidney stones in november that required a stent in the kidney.He is receiving a nuclear stress test and kidney stone ablation.She also reports he had a fall at the last doctor's visit and did not have any injuries resulting from the fall.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC ONE PFS 8MG
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
GENZYME CORPORATION
MDR Report Key18563793
MDR Text Key333565334
Report NumberMW5150632
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient Family Member or Friend
Type of Report Initial
Report Date 01/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/22/2024
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age83 YR
Patient SexMale
-
-